Cullen/Frost Bankers, Inc. Viatris Inc Transaction History
Cullen/Frost Bankers, Inc.
- $7.21 Billion
- Q4 2024
A detailed history of Cullen/Frost Bankers, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 1,024 shares of VTRS stock, worth $10,864. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,024
Previous 3,717
72.45%
Holding current value
$10,864
Previous $43,000
72.09%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding VTRS
# of Institutions
1,111Shares Held
969MCall Options Held
2.69MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA142MShares$1.51 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$983 Million0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$670 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$664 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$518 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.9B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...